Related Experiment Video
Updated: Feb 7, 2026

Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock
Published on: June 29, 2017
Genomic Characterization of 30 Lytic Klebsiella pneumoniae Bacteriophages
Abstract:
The spread and rise of antimicrobial resistance poses a risk to public health due to limited effective treatment options. Alternative antimicrobials that are effective against gram-negative multi-drug resistant pathogens. The increasing rate of carbapenem resistance observed in Klebsiella pneumoniae , indicates the need for alternative antimicrobial options. Bacteriophages that target Klebsiella pneumoniae are promising alternative antimicrobial option, with successful treatments being reported. Here we characterized 30 lytic bacteriophages from various environmental sources and tested their effectiveness against nine clinically relevant carbapenem-resistant K. pneumoniae isolates. These phages were characterized through genomic sequencing, bioinformatic analysis, virulence in liquid medium, and host range on different mediums. Bioinformatic analysis revealed a diverse collection of phages that span 9 ICTV recognized families and 13 genera with genome sizes ranging from 39-349 kbp. The phages were able to inhibit bacterial growth, and no virulence or antibiotic resistance genes were detected within the phage genomes. Host range testing demonstrated phages with broad host range have varying infectivity when plated on different common growth mediums. This study includes candidate phages for further potential development as potential antimicrobial agents against CR-KP, and the complexity in understanding phage-host dynamics of non-capsule phages that target against K. pneumoniae .
Insights
Thirty bacteriophages were studied as potential treatments for carbapenem-resistant Klebsiella pneumoniae (CR-KP). These phages inhibited bacterial growth and lacked harmful genes, showing promise as antimicrobial alternatives.
Area of Science:
- Microbiology
- Genomics
- Public Health
Background:
- Antimicrobial resistance, particularly carbapenem resistance in Klebsiella pneumoniae, is a significant public health threat due to limited treatment options.
- Bacteriophages (phages) are emerging as a promising alternative antimicrobial strategy against multi-drug resistant pathogens.
Purpose of the Study:
- To characterize lytic bacteriophages targeting carbapenem-resistant Klebsiella pneumoniae (CR-KP).
- To evaluate the effectiveness and safety of these phages as potential antimicrobial agents.
Main Methods:
- Isolation and characterization of 30 lytic bacteriophages from environmental sources.
- Genomic sequencing and bioinformatic analysis of phage genomes.
- Assessment of phage virulence, antibiotic resistance genes, and host range on various media against CR-KP isolates.
Main Results:
- Genomic analysis revealed a diverse phage collection across 9 families and 13 genera, with genome sizes from 39-349 kbp.
- All characterized phages demonstrated the ability to inhibit bacterial growth.
- No virulence or antibiotic resistance genes were detected in the phage genomes.
- Broad host range phages exhibited variable infectivity depending on the growth medium.
Conclusions:
- The study identified candidate phages for potential development as antimicrobial agents against CR-KP.
- Understanding phage-host dynamics, especially for non-capsule phages targeting Klebsiella pneumoniae, remains complex.
More Related Videos
12:08Hybrid De Novo Genome Assembly for the Generation of Complete Genomes of Urinary Bacteria using Short- and Long-read Sequencing Technologies
Published on: August 20, 2021
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
DNA Bacteriophages
Genomics
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology